Avita Medical | 1811094D - Cost Of Sales

Stock Price
1.15
Daily Change
-0.02 -1.71%
Monthly
-16.67%
Yearly
-45.75%
Q2 Forecast
1.16

Avita Medical reported AUD3.3M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
Celltrion KRW 107.42B 295.44B Dec/2025
Clinuvel Pharmaceuticals AUD 2.64M 1.06M Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 10.63B 1.23B Dec/2025
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Medical Developments International AUD 7.09M 4.91M Dec/2025
Nanosonics AUD 24.22M 1.11M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organigram Holdings CAD 56.93M 20.53M Dec/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Pharma Mar EUR 3.66M 116K Mar/2026
Polynovo AUD 9.02M 3.51M Dec/2025
Qiagen NV USD 217.43M 29.65M Dec/2025
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 536.28M 21.52M Dec/2025
Sartorius EUR 484.6M 46.6M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025
Tilray USD 164.37M 8.41M Sep/2025
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026